Shigenori Kadowaki Selected Research

Phosphotransferases (Kinase)

7/2023

Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigenori Kadowaki Research Topics

Disease

41	Neoplasms (Cancer) 10/2023 - 06/2004
32	Stomach Neoplasms (Stomach Cancer) 04/2024 - 07/2012
23	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 06/2009
12	Adenocarcinoma 06/2023 - 01/2016
12	Esophageal Squamous Cell Carcinoma 01/2023 - 11/2013
9	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2009
8	Disease Progression 01/2023 - 01/2013
6	Neutropenia 11/2023 - 11/2013
5	Squamous Cell Carcinoma of Head and Neck 03/2024 - 04/2009
5	Ascites 01/2023 - 06/2009
5	Esophageal Neoplasms (Esophageal Cancer) 02/2021 - 08/2015
3	Febrile Neutropenia 11/2023 - 01/2017
3	Diarrhea 11/2020 - 11/2011
3	Mucositis 11/2020 - 11/2011
3	Anorexia 01/2019 - 04/2009
3	Leukopenia 01/2019 - 04/2009
3	Nausea 01/2017 - 04/2009
3	Stomatitis 11/2013 - 04/2009
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 11/2019
2	Microsatellite Instability 02/2021 - 01/2019
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2020 - 01/2019
2	Anemia 01/2019 - 01/2017
2	Brain Diseases (Brain Disorder) 01/2019 - 06/2017
2	Hypertension (High Blood Pressure) 01/2019 - 01/2017
2	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2017
2	Head and Neck Neoplasms (Head and Neck Cancer) 11/2018 - 04/2009
2	Sarcopenia 10/2018 - 06/2017
2	Disseminated Intravascular Coagulation 09/2017 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2013 - 04/2006
1	Nasopharyngeal Carcinoma 03/2024
1	Thyroid Neoplasms (Thyroid Cancer) 02/2024
1	Rectal Neoplasms (Rectal Cancer) 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Hemolytic Anemia 01/2022
1	Sepsis (Septicemia) 01/2022
1	Liver Failure 01/2022
1	Sudden Death 01/2022

Drug/Important Bio-Agent (IBA)

16	Fluorouracil (Carac)FDA LinkGeneric 03/2024 - 09/2004
15	NivolumabIBA 06/2023 - 11/2018
14	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2024 - 02/2014
14	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 04/2009
11	Leucovorin (Folinic Acid)FDA Link 03/2023 - 09/2004
10	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 06/2009
10	Bevacizumab (Avastin)FDA Link 11/2023 - 02/2014
9	PlatinumIBA 01/2023 - 01/2017
8	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2017
8	Trastuzumab (Herceptin)FDA Link 04/2024 - 01/2013
7	Cetuximab (Erbitux)FDA Link 03/2024 - 06/2009
6	Immune Checkpoint InhibitorsIBA 10/2023 - 11/2019
6	Taxoids (Taxanes)IBA 06/2023 - 11/2018
6	RamucirumabIBA 01/2023 - 01/2018
6	S-1 plus cisplatinIBA 01/2022 - 07/2012
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2016
5	human ERBB2 proteinIBA 01/2022 - 01/2016
5	regorafenibIBA 11/2019 - 01/2017
4	trifluridine tipiracil drug combinationIBA 11/2023 - 01/2017
4	Paclitaxel (Taxol)FDA LinkGeneric 07/2021 - 01/2018
4	Docetaxel (Taxotere)FDA Link 02/2021 - 11/2013
3	taxaneIBA 01/2023 - 09/2017
3	BilirubinIBA 01/2019 - 01/2016
3	AntibodiesIBA 11/2018 - 12/2012
3	Epidermal Growth Factor (EGF)IBA 01/2014 - 12/2012
2	pembrolizumabIBA 03/2024 - 12/2021
2	Gemcitabine FDA Link 03/2024 - 09/2004
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2023 - 07/2023
2	130-nm albumin-bound paclitaxelIBA 01/2023 - 09/2017
2	Growth Factor ReceptorsIBA 01/2023 - 03/2016
2	Monoclonal AntibodiesIBA 01/2023 - 01/2022
2	andecaliximabIBA 01/2022 - 01/2022
2	Cytotoxins (Cytolysins)IBA 04/2020 - 08/2017
2	Panitumumab (Vectibix)FDA Link 01/2020 - 03/2016
2	Dacarbazine (DIC)FDA LinkGeneric 09/2017 - 01/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017 - 01/2017
2	ParaffinIBA 01/2016 - 06/2004
1	B7-H1 AntigenIBA 03/2024
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2024
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 02/2024
1	binimetinibIBA 02/2024
1	encorafenibIBA 02/2024
1	Dihydrotachysterol (AT 10)IBA 02/2024
1	Antineoplastic Agents (Antineoplastics)IBA 08/2023
1	TropomyosinIBA 07/2023
1	Phosphotransferases (Kinase)IBA 07/2023
1	Albumin-Bound Paclitaxel FDA Link 01/2023
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2022
1	EnzymesIBA 01/2022
1	Capecitabine (Xeloda)FDA Link 01/2022
1	quinone (benzoquinone)IBA 11/2021
1	Oxidoreductases (Dehydrogenase)IBA 11/2021
1	NAD (NADH)IBA 11/2021

Therapy/Procedure

54	Drug Therapy (Chemotherapy) 03/2024 - 06/2004
27	Therapeutics 03/2024 - 04/2004
6	Adjuvant Chemotherapy 01/2022 - 09/2004
5	Immunotherapy 10/2023 - 04/2020
5	Chemoradiotherapy 01/2023 - 11/2011
3	Palliative Care (Palliative Therapy) 01/2021 - 01/2007
3	Drug Tapering 06/2017 - 11/2011
3	Neoadjuvant Therapy 10/2016 - 09/2004
2	Combination Drug Therapy (Combination Chemotherapy) 08/2014 - 07/2012
1	Intravenous Infusions 01/2022